RxDoctor Payments Data

Andrew Kumpuris

Cardiovascular Disease · Little Rock, ARNPI 1669483293

Payments from drug & device makers

$1,327in general payments, 2019–2025

Across 91 payments — averaging $14.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$307
  • AstraZeneca$122
  • Pfizer$117
  • Boehringer Ingelheim$112
  • Amgen$107
  • Johnson & Johnson$107
  • plus $455 from 13 others

What the payments were for

  • Food & beverage$1,327100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,327 in reported general payments places this provider in the 30th percentile of 130 cardiovascular disease providers in Arkansas.

See all cardiovascular disease providers in Arkansas

Other cardiovascular disease in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →